<DOC>
	<DOCNO>NCT00826839</DOCNO>
	<brief_summary>Hundreds thousand couple United States experience infertility year . When initial measure help , couple require process call ovarian stimulation vitro fertilization ( IVF ) . Usually , woman produce one egg month . Ovarian stimulation help woman make one egg per month . However , involve take hormone stimulate ovary produce many egg one time . The stimulatory hormone inject small needle . The egg remove ovary surgical procedure place dish fertilization sperm form embryo . The embryos grown laboratory replace woman 's uterus 3-5 day later . The stimulation ovaries important . Some patient undergo ovarian stimulation IVF respond treatment . This difficult situation even though several ovarian stimulation protocol use poor responder patient , clear protocol work best . In fact , two commonly use protocol directly compare . This study randomize ( like flip coin ) couple history low response go start IVF treatment two group . In one group female partner use protocol call `` E2 patch/antagonist '' . These woman use estrogen patch inject antagonist several day start injectable fertility medication . The group use protocol call `` OCP/microdose '' . This group woman use oral contraceptive pill ( OCPs ) small dos lupron along injectable fertility medication . We follow progress see many egg produce many woman get pregnant .</brief_summary>
	<brief_title>Oral Microdose Lupron Versus Luteal Estradiol Trial Poor Responder In Vitro Fertilization ( IVF ) Patients</brief_title>
	<detailed_description>Patients difficulty conceive naturally often seek medical advice . These patient often undergo initial treatment insemination use oral injectable medication . However , fails achieve pregnancy , patient often undergo vitro fertilization ( IVF ) . IVF process involve protocol injectable medication stimulate ovary produce several egg . These egg retrieve ultrasound guidance fertilize laboratory . After 3-5 day growth laboratory , appropriate number embryo transfer back patient 's uterus . Sometimes , patient go ovarian stimulation IVF respond well . These patient low estrogen level , egg retrieve , few embryo transfer back uterus . Overall , low pregnancy rate patient . It clear medication protocol would give high chance pregnancy . Two protocol , one call `` E2/antagonist '' protocol call `` OCP/microdose '' protocol , routinely use poor responder patient . But , never prospectively compare possible say whether one approach well . In order determine medication protocol result pregnancy , propose randomize poor responder patient schedule undergo treatment IVF one two protocol . These two protocol already standard care IVF center around world . Following randomization , clinical care study participant IVF patient . Specifically , adjustment medication , egg retrieval , embryo transfer procedures identical non-study patient undergo IVF . HYPOTHESIS We hypothesize poor responder patient undergo ovarian stimulation IVF E2/antagonist protocol high pregnancy rate OCP/microdose group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Hormone Antagonists</mesh_term>
	<mesh_term>Ganirelix</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Combined</mesh_term>
	<criteria>Females couple indication IVF history poor response define one following : Cancellation IVF due inadequate follicular development Peak estradiol &lt; 1000 pg/mL &lt; 6 oocyte retrieve Age ≥18 year time signing informed consent Availability ejaculatory sperm ( use donate and/or cryopreserved sperm allow ) Willing able sign inform consent Prior use E2/ganirelix OCP/microdose protocol Less 2 ovary ovarian abnormality Presence uncorrected unilateral bilateral hydrosalpinx Presence clinically relevant pathology affect uterine cavity intramural fibroid ≥ 5cm Contraindications use gonadotropin ( e.g . tumor , pregnancy/lactation , undiagnosed vaginal bleeding , hypersensitivity , clinically significant ovarian cyst ) Contraindications use oral contraceptive pill ( h/o thromboembolism , breast cancer , undiagnosed vaginal bleeding ) Contraindications use estrogen patch ( h/o thromboembolism , breast cancer , undiagnosed vaginal bleeding ) Abnormal karyotyping patient partner ( karyotyping perform ) Hypersensitivity concomitant medication prescribe part treatment regimen protocol Transfer embryo patient plan ( i.e . gestational carrier use plan , embryo frozen ) Unable give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>In vitro fertilization</keyword>
	<keyword>Poor responder patient</keyword>
	<keyword>Randomized clinical trial</keyword>
	<keyword>Estrogen patch</keyword>
	<keyword>Gonadotropin-releasing hormone antagonist</keyword>
	<keyword>Oral contraceptive pill</keyword>
	<keyword>Microdose lupron</keyword>
</DOC>